Cost-consequence analysis of Pharmaceutical Care program for systemic arterial hypertension in the public health system in Brazil
Braz. J. Pharm. Sci. (Online); 53 (3), 2017
ABSTRACT In Brazil, 80% of hypertensive patients have no blood pressure controlled, this fact has caused severe financial consequences for the public health system (PHS) and the Pharmaceutical Care (PC) has emerged as an effective alternative. The aim of this study was to analyze the costs and outcomes o...